# Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan

> **NCT01389687** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 74 (actual)

## Conditions studied

- Poliomyelitis
- Polio

## Interventions

- **BIOLOGICAL:** Inactive Poliovirus Vaccine

## Key facts

- **NCT ID:** NCT01389687
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2013-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389687, "Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01389687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*